
Healthcare / Pharmaceuticals Sector · BSE
Chandra Bhagat Pharma Limited, established in 2003, is engaged in marketing lifesaving medicines in India across therapeutic areas such as cardiovascular care, cancer treatment, antibiotics, hormones, anesthesia, pediatrics, nephrology, antiviral, antifungal, and neurology. The company operates under its own brand with the support of an in-house sales team and distribution network that supplies healthcare centers and hospitals, while also dealing in specialty chemicals. In addition to finished formulations, it imports, supplies, and undertakes indenting of active pharmaceutical ingredients and intermediates, and holds FDA approval to manufacture formulations through contract manufacturers. Its storage facilities are located on a leased basis in Bhiwandi, Thane, Maharashtra, and the company also exports pharmaceutical products to international markets including DR Congo, Bolivia, and the Philippines.
Price Band
₹51
Issue Size
₹10.20 Cr
Lot Size
2000 shares
GMP
Est. Listing
₹51
at current GMP
Subscribed
—
Open
31 Jan 2020
Close
6 Feb 2020
Allotment
12 Feb 2020
Refund
13 Feb 2020
Demat Credit
14 Feb 2020
Listing
14 Feb 2020
Overall Subscription
0.00x
Total Demand
QIB Multiplier
0.00x
Institutions & Funds
NII / HNI
0.00x
High Net-Worth
Retail (RII)
0.00x
Individual Bidders
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| Qualified Institutional (QIB) | 1,000,000 | — | 0.00x |
| Non-Institutional (NII / HNI) | 300,000 | — | 0.00x |
| Retail Individual (RII) | 700,000 | — | 0.00x |
| Total | 2,000,000 | 0 | 0.00x |
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| Retail (RII) | 350 | 350 | 1.00x |
| HNIs (10L +) | 2 | 2 | 1.00x |
| HNIs (2-10L) | 11 | 11 | 1.00x |
| Total Applications | 363 | 363 | 1.00x |
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
Chandra Bhagat Pharma Limited is bringing an initial public offering (IPO) in the Healthcare / Pharmaceuticals Sector sector with an aggregate issue size of ₹10.2 Crores. The shares are offered at a price band of ₹51 to ₹51 per equity share on BSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 2000 shares (approx. ₹1,02,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Link Intime India Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2020-02-14, while un-allotted funds or UPI block mandates will be released on 2020-02-13.
Currently, Chandra Bhagat Pharma Limited IPO Grey Market Premium (GMP) is not actively quoted or is quoted flat at ₹0. The shares are expected to list close to the issue price band of ₹51 to ₹51 per equity share.
The retail lot size is 2000 shares requiring a minimum application amount of ₹1,02,000. Expected listing price is ₹51 per equity share.
The Chandra Bhagat Pharma Limited IPO aggregate issue size is ₹10.2 Crores with an equity price band set at ₹51 to ₹51 per equity share. The retail lot size is 2000 shares requiring a minimum capital outlay of approx. ₹1,02,000.
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 0.00x (Retail: 0.00x, QIB: 0.00x, NII: 0.00x). You can track live multiples directly on our dedicated subscription page.
The basis of allotment will be published on the official registrar portal (Link Intime India Private Limited) and the BSE status verification website on or around 2020-02-12. Investors can verify status using PAN card or application number.
Chandra Bhagat Pharma Limited shares are scheduled to list on BSE on 2020-02-14.